Your browser doesn't support javascript.
loading
Pattern of Prescribing Drugs in Chronic Obstructive Pulmonary Disease in a Tertiary Care Hospital of Bangladesh.
Aktar, M; Ahmed, A U; Sabrin, F; Rana, M S; Rasna, S S; Zannat, K E; Afrin, A; Sultana, S; Jahan, S; Nahar, S; Shimu, R N.
Afiliação
  • Aktar M; Dr Mahmuda Aktar, Lectuer, Department of Pharmacology, Mymensingh Medical College (MMC), Mymensingh, Bangladesh; E-mail: drmahmuda.17.tuba@gmail.com.
Mymensingh Med J ; 32(3): 653-658, 2023 Jul.
Article em En | MEDLINE | ID: mdl-37391955
ABSTRACT
Chronic obstructive pulmonary disease (COPD) is a chronic obstructive disease of the airways. It is one of the most common and important chronic respiratory conditions in terms of years lived with disability. Incidence is increasing in Bangladesh like other developing countries. To evaluate drug prescription pattern for COPD, this cross-sectional, observational study was conducted from January to December in 2020 at the Department of Pharmacology in collaboration with the Department of Medicine in Mymensingh Medical College, Bangladesh. A total of 168 patients were selected for the study by non-random purposive sampling technique. Age distribution indicates that 31.5% of patients were in the 50-59 years age group and males were 93.5%. The majority (82.1%) of the participants were smokers. In this study, majority (34.12%) of the drugs were used as oral form and second most common dosage form was nebulization (26.75%). Bronchodilators were mostly prescribed 652(57.19%), followed by corticosteroids 222(19.47%) and antibiotics 165(14.47%) among drugs used for COPD. Beta sympathomimetics 322(45.49%) were mostly prescribed, followed by anticholinergics 186(28.52%) and methylxanthines 144(22.08%) as bronchodilators. Out of 1140 drugs for COPD, 53.06% and 34.12% were delivered as inhalation and oral forms, respectively. Inhalation route was the most (60.37%) preferred one over oral route (37.63%) for steroid use. The most of the patients [152 (90.48%)] were treated with combination therapy. Mostly (39.6%) used Fixed Dose Combination (FDC) therapy was salbutamol and ipratropium bromide followed by salmeteroal and Fluticasone (30.83%). Both FDC were prescribed in 57.7% of study population. Considering nomenclature, trade name was used in 24.4% of prescription.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Broncodilatadores / Doença Pulmonar Obstrutiva Crônica Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Mymensingh Med J Assunto da revista: MEDICINA Ano de publicação: 2023 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Broncodilatadores / Doença Pulmonar Obstrutiva Crônica Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Mymensingh Med J Assunto da revista: MEDICINA Ano de publicação: 2023 Tipo de documento: Article
...